Sign Up | Log In | What is SocialPicks?

7 pts

Opinion on Mylan Laboratories Inc (MYL) Sector: Healthcare > Industry: Biotechnology & Drugs
Mylan Laboratories Inc

Jul 28, 2009 01:44 PM GMT

Marian Filo

Return	Risk
-24.55%	HIGH

Principal

Profile & Performance

Subscribe to author

Mylan ( MYL | Chart | News | PowerRating ) - Dropped the most in the S&P 500 after rumors of lax quality control at the US's largest generic drug maker surfaced. Shares fell by 12.64% or $1.75 to $12.10/share.

MYL: This call was made on 07/28/09 @ $12.1

Rating:	$12.1 (07/28/09)
Gain/Loss:	+45.04% in 118 days
Allocation:	0.0% of portfolio

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.75%	378
2	Gerald Greene	18.14	+69.56%	208
3	stockmarketfunding.com	17.66	+25.70%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.10%	38

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
CSCO	Cisco Systems Inc
MO	Altria Group Inc
MA	MasterCard Inc
KO	The CocaCola Company
MSFT	Microsoft Corp
POT	Potash Corp. of Saskatchewan Inc.

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla
DNDN		BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla
ONCY		Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten
JNJ		Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla
CERS		BioMed News Bytes: GeoVax, Cerus, Discovery Labs by Mike Havrilla

... more »

Mylan Laboratories Inc (MYL)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

79.5%

Top:

100.0%

Get Daily Email Alerts

Subscribe to Marian Filo

Receive Free Ideas Daily for This Sector

Latest Picks by Marian Filo

Symbol	SP Sentiment	Return	Since
IBB		-1.96%	11/16/09
ARE		-5.03%	11/16/09
ESE		-4.01%	11/16/09
SSY	N/A	-10.29%	11/16/09
NLST	N/A	+62.64%	11/16/09

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on Mylan Laboratories Inc (MYL) Sector: Healthcare > Industry: Biotechnology & Drugs Mylan Laboratories Inc

Opinion on Mylan Laboratories Inc (MYL) Sector: Healthcare > Industry: Biotechnology & Drugs
Mylan Laboratories Inc